Compare · ECL vs WALD
ECL vs WALD
Side-by-side comparison of Ecolab Inc. (ECL) and Waldencast plc (WALD): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both ECL and WALD operate in Package Goods/Cosmetics (Consumer Discretionary), so they compete in similar markets.
- ECL is the larger of the two at $72.12B, about 303.9x WALD ($237.3M).
- Over the past year, ECL is down 3.7% and WALD is down 25.7% - ECL leads by 22.0 points.
- ECL has been more active in the news (23 items in the past 4 weeks vs 4 for WALD).
- ECL has more recent analyst coverage (25 ratings vs 11 for WALD).
- Company
- Ecolab Inc.
- Waldencast plc
- Price
- $255.68-0.21%
- $1.77-4.31%
- Market cap
- $72.12B
- $237.3M
- 1M return
- -0.01%
- +97.22%
- 1Y return
- -3.70%
- -25.73%
- Industry
- Package Goods/Cosmetics
- Package Goods/Cosmetics
- Exchange
- NYSE
- NASDAQ
- IPO
- 2021
- News (4w)
- 23
- 4
- Recent ratings
- 25
- 11
Ecolab Inc.
Ecolab Inc. provides water, hygiene, and infection prevention solutions and services worldwide. Its Global Industrial segment offers water treatment and process applications, and cleaning and sanitizing solutions to manufacturing, food and beverage processing, transportation, chemical, metals and mining, power generation, pulp and paper, commercial laundry, petroleum, and petrochemical industries. The company's Global Institutional & Specialty segment provides specialized cleaning and sanitizing products to the foodservice, hospitality, lodging, government and education, and retail industries. Its Global Healthcare & Life Sciences segment offers specialized cleaning and sanitizing products to the healthcare, personal care, and pharmaceutical industries, such as infection prevention and surgical solutions, and end-to-end cleaning and contamination control solutions under the Ecolab, Microtek, and Anios brand names. The company's Other segment offers pest elimination services to detect, eliminate, and prevent pests, such as rodents and insects in restaurants, food and beverage processors, educational and healthcare facilities, hotels, quick service restaurant and grocery operations, and other institutional and commercial customers. This segment also provides colloidal silica for binding and polishing applications in semiconductor, catalyst, and aerospace component manufacturing, as well as chemical industries; and products and services that manage wash process through custom designed programs, premium products, dispensing equipment, water and energy management, and reduction, as well as real time data management. It sells its products through field sales and corporate account personnel, distributors, and dealers. The company was founded in 1923 and is headquartered in St. Paul, Minnesota.
Waldencast plc
Waldencast Acquisition Corp. focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It intends to identify businesses in the beauty, personal care, and wellness sectors. The company was incorporated in 2020 and is based in White Plains, New York.
Latest ECL
- Ecolab Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits
- SEC Form SD filed by Ecolab Inc.
- Director Vautrinot Suzanne M exercised 2,000 shares at a strike of $125.67, covered exercise/tax liability with 996 shares and sold $266,040 worth of shares (1,004 units at $264.98) (SEC Form 4)
- Ecolab Schedules Webcast of Industry Conference for June 2, 2026
- Ecolab upgraded by UBS with a new price target
- SEC Form 424B5 filed by Ecolab Inc.
- SEC Form 4 filed by Director Zillmer John J
- SEC Form 4 filed by Director Whalen Julie
- SEC Form 4 filed by Director Vautrinot Suzanne M
- SEC Form FWP filed by Ecolab Inc.
Latest WALD
- SEC Form 6-K filed by Waldencast plc
- Waldencast Announces Sale of Obagi Medical to Bridgepoint
- Obagi Medical Shares New Data on Recent Innovations at Music City Symposium for Cosmetic Advances & Laser Education (SCALE) Meeting
- Obagi and Next Health Partner to Launch "The Skin Recharge Station" Pop-Up Experience
- Obagi Medical Unveils New Mineral Sunscreen Designed to Protect Sensitive and Post-Procedure Skin*
- Waldencast announces conclusion of SEC investigation
- SEC Form 6-K filed by Waldencast plc
- Obagi Medical Introduces NU-GEN™ Cellular Renewal Serum Designed to Visibly Rewind Skin's Age and Restore Visible Youthfulness
- Obagi Medical and ProMD Announce Collaboration in the ALOHA Program to Advance Clinical Evidence with Obagi® saypha® MagIQ™
- SEC Form 3 filed by new insider Brousset Michel